TRULEF Trademark

Trademark Overview


On Tuesday, September 16, 2008, a trademark application was filed for TRULEF with the United States Patent and Trademark Office. The USPTO has given the TRULEF trademark a serial number of 77571069. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, July 30, 2009. This trademark is owned by Pfizer Inc.. The TRULEF trademark is filed in the Pharmaceutical Products category with the following description:

veterinary preparations and substances for the prevention and treatment of ocular disorders, oral diseases, disorders of the nervous system, the blood and immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the digestive system, the genitourinary system, and the reproductive system; veterinary preparations and substances for the treatment and prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations and substances for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; nutritional additives and food supplements; veterinary dental preparations in the nature of a pharmaceutical drug or vaccine for the treatment and prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; Pharmaceutical preparations for relieving teething pains and toothaches; anti-infectives; anti-bacterials; antivirals; antibiotics; antifungals; anthelminti...
trulef

General Information


Serial Number77571069
Word MarkTRULEF
Filing DateTuesday, September 16, 2008
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, July 30, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesveterinary preparations and substances for the prevention and treatment of ocular disorders, oral diseases, disorders of the nervous system, the blood and immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the digestive system, the genitourinary system, and the reproductive system; veterinary preparations and substances for the treatment and prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations and substances for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; nutritional additives and food supplements; veterinary dental preparations in the nature of a pharmaceutical drug or vaccine for the treatment and prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; Pharmaceutical preparations for relieving teething pains and toothaches; anti-infectives; anti-bacterials; antivirals; antibiotics; antifungals; anthelmintics; parasiticides; analgesics and anti-allergens, all of the foregoing for treating felines, canines, bovines, porcines, equines, rabbits, poultry, goats and sheep

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 19, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Thursday, July 30, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, July 30, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, December 18, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 18, 2008NON-FINAL ACTION E-MAILED
Thursday, December 18, 2008NON-FINAL ACTION WRITTEN
Tuesday, December 16, 2008ASSIGNED TO EXAMINER
Friday, September 19, 2008NEW APPLICATION ENTERED IN TRAM